Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Serum FAM19A5 Level in Egyptian Patients With Neuromyelitis Optica Spectrum Disorder

NCT05446701 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05446701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05446701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Serum FAM19A5 Level in Egyptian Patients With Neuromyelitis Optica Spectrum Disorder
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
April 30, 2024
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

assessment of serum fam19a5level in egyptian patients with nmosd